🇺🇸 FDA
Pipeline program

Niraparib Placebo Capsules, Niraparib Placebo Tablets, G5W (5% glucose in water), JEMPERLI 500 mg concentrate for solution for infusion

4010-03-001

Phase 3 small_molecule active

Quick answer

Niraparib Placebo Capsules, Niraparib Placebo Tablets, G5W (5% glucose in water), JEMPERLI 500 mg concentrate for solution for infusion for Recurrent or primary advanced (Stage III or IV) endometrial cancer is a Phase 3 program (small_molecule) at TESARO Bio Netherlands B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
TESARO Bio Netherlands B.V.
Indication
Recurrent or primary advanced (Stage III or IV) endometrial cancer
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials